Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Effron

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Journal of the American Heart Association|January 27, 2016
How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical StudiesArun Krishnamoorthy, Eric D Peterson, J David Knight, et al.
Journal of the American Heart Association|September 25, 2016
Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) StudyAmit N Vora, Eric D Peterson, Lisa A McCoy, et al.
Journal of the American College of Cardiology|February 4, 2014
Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary interventionTracy Y Wang, Lisa McCoy, Timothy D Henry, et al.
American Heart Journal|November 19, 2011
Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational researchChee Tang Chin, Tracy Y Wang, Kevin J Anstrom, et al.
Circulation. Cardiovascular Interventions|May 31, 2015
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy studyTracy Y Wang, Timothy D Henry, Mark B Effron, et al.
Circulation|August 27, 2003
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialJames E Tcheng, David E Kandzari, Cindy L Grines, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 12, 2015
One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrelJason C Simeone, Cliff Molife, Elizabeth Marrett, et al.
Thrombosis and Haemostasis|September 7, 2013
Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathwaysOscar Ö Braun, Dominick J Angiolillo, Jose L Ferreiro, et al.
Clinical Trials (London, England)|February 5, 2021
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trialAjar Kochar, Mary B Summers, Catherine P Benziger, et al.
BMJ Open|August 8, 2024
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trialGuillaume Marquis-Gravel, Hillary Mulder, Lisa M Wruck, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Journal of the American Heart Association|January 27, 2016
How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical StudiesArun Krishnamoorthy, Eric D Peterson, J David Knight, et al.
Journal of the American Heart Association|September 25, 2016
Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) StudyAmit N Vora, Eric D Peterson, Lisa A McCoy, et al.
Journal of the American College of Cardiology|February 4, 2014
Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary interventionTracy Y Wang, Lisa McCoy, Timothy D Henry, et al.
American Heart Journal|November 19, 2011
Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational researchChee Tang Chin, Tracy Y Wang, Kevin J Anstrom, et al.
Circulation. Cardiovascular Interventions|May 31, 2015
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy studyTracy Y Wang, Timothy D Henry, Mark B Effron, et al.
Circulation|August 27, 2003
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialJames E Tcheng, David E Kandzari, Cindy L Grines, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 12, 2015
One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrelJason C Simeone, Cliff Molife, Elizabeth Marrett, et al.
Thrombosis and Haemostasis|September 7, 2013
Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathwaysOscar Ö Braun, Dominick J Angiolillo, Jose L Ferreiro, et al.
Clinical Trials (London, England)|February 5, 2021
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trialAjar Kochar, Mary B Summers, Catherine P Benziger, et al.
BMJ Open|August 8, 2024
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trialGuillaume Marquis-Gravel, Hillary Mulder, Lisa M Wruck, et al.
Pageof 10